Modulation of microRNA 20b with resveratrol and longevinex is linked with their potent anti-angiogenic action in the ischaemic myocardium and synergestic effects of resveratrol and γ-tocotrienol

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 10, 2012, Pages 2504-2517

  Mukhopadhyay, Partha ^a   Das, Somak ^b   Ahsan, Md Kaimul ^c   Otani, Hajime ^d   Das, Dipak K ^b  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY   (United States)

^d KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

tocotrienol; Cardiovascular; Ischaemia reperfusion; MicroRNA; Redox; Resveratrol longevinex

Indexed keywords

ALPHA TOCOPHEROL; ANGIOGENESIS INHIBITOR; CHROMAN DERIVATIVE; DRUG DERIVATIVE; HIF1A PROTEIN, RAT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MICRORNA; MIRN20 MICRORNA, RAT; PLASTOCHROMANOL 8; REACTIVE OXYGEN METABOLITE; RESVERATROL; STILBENE DERIVATIVE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANIMAL; APOPTOSIS; ARTICLE; CONFOCAL MICROSCOPY; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION PROFILING; GENETICS; HEART; HEART MUSCLE; HEART MUSCLE ISCHEMIA; MALE; METABOLISM; METHODOLOGY; MULTIVARIATE ANALYSIS; PATHOLOGY; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANGIOGENESIS INHIBITORS; ANIMALS; APOPTOSIS; CHROMANS; DOWN-REGULATION; DRUG SYNERGISM; GENE EXPRESSION PROFILING; HEART; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICRORNAS; MICROSCOPY, CONFOCAL; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; STILBENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITAMIN E;

RATTUS;

EID: 84866751141     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01480.x     Document Type: Article

References (41)

1. Bhat KP, Pezzuto JM. Cancer chemopreventive activity of resveratrol. Ann N Y Acad Sci. 2002; 957: 210-29.
2. Das DK, Mukherjee S, Ray D. Resveratrol and red wine, healthy heart and longevity. Heart Fail Rev. 2010, 15:467-77.
3. Petrovski G, Gurusamy N, Das DK. Resveratrol in cardiovascular health and disease. Ann N Y Acad Sci. 2011; 1215: 22-33.
4. Bertelli AA, Das DK. Grapes, wines, resveratrol, and heart health. J Cardiovasc Pharmacol. 2009; 54: 468-76.
5. Mukherjee S, Lekli I, Gurusamy N, et al. Expression of the longevity proteins by both red and white wines and their cardioprotective components, resveratrol, tyrosol, and hydroxytyrosol. Free Radic Biol Med. 2009; 46: 573-8.
6. Lekli I, Ray D, Mukherjee S, et al. Co-ordinated autophagy with resveratrol and gamma-tocotrienol confers synergetic cardioprotection. J Cell Mol Med. 2009, 14: 2506-18.
7. Nakagawa K, Shibata A, Yamashita S, et al. In vivo angiogenesis is suppressed by unsaturated vitamin E, tocotrienol. J Nutr. 2007; 137: 1938-43.
8. Tiwari V, Kuhad A, Bishnoi M, et al. Chronic treatment with tocotrienol, an isoform of vitamin E, prevents intracerebroventricular streptozotocin-induced cognitive impairment and oxidative-nitrosative stress in rats. Pharmacol Biochem Behav. 2009; 93: 183-9.
9. Das DK, Maulik N. Conversion of death signal into survival signal by redox signaling. Biochemistry (Mosc). 2004; 69: 10-7.
10. Mukhopadhyay P, Mukherjee S, Ahsan K, et al. Restoration of altered microRNA expression in the ischemic heart with resveratrol. PLoS One. 2010; 5: e15705.
11. Mukhopadhyay P, Pacher P, Das DK. MicroRNA signatures of resveratrol in the ischemic heart. Ann N Y Acad Sci. 2011; 1215: 109-16.
12. Robich MP, Chu LM, Chaudray M, et al. Anti-angiogenic effect of high-dose resveratrol in a swine model of metabolic syndrome. Surgery. 2010; 148: 453-62.
13. Lekli I, Ray D, Mukherjee S, et al. Co-ordinated autophagy with resveratrol and gamma-tocotrienol confers synergetic cardioprotection. J Cell Mol Med. 2010; 14: 2506-18.
14. Hattori R, Otani H, Maulik N, et al. Pharmacological preconditioning with resveratrol: role of nitric oxide. Am J Physiol Heart Circ Physiol. 2002; 282: H1988-95.
15. Mukherjee S, Ray D, Lekli I, et al. Effects of longevinex on cardioprotection: its mechanism of action. Can J Pharmacol Physiol 2010, 88: 1017-25.
16. Imamura G, Bertelli AA, Bertelli A, et al. Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice. Am J Physiol Heart Circ Physiol. 2002; 282: H1996-2003.
17. Mukhopadhyay P, Rajesh M, Batkai S, et al. Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro. Am J Physiol Heart Circ Physiol. 2009; 296: H1466-83.
18. Mukhopadhyay P, Rajesh M, Batkai S, et al. CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes. Cardiovasc Res. 2010; 85: 773-84.
19. Esterhuyse JS, van Rooyen J, Strijdom H, et al. Proposed mechanisms for red palm oil induced cardioprotection in a model of hyperlipidaemia in the rat. Prostaglandins Leukot Essent Fatty Acids. 2006; 75: 375-84.
20. Gorbunov N, Petrovski G, Gurusamy N, et al. Regeneration of infarcted myocardium with resveratrol-modified cardiac stem cells. J Cell Mol Med. 2011. doi: 10.1111/j.1582-4934.2011.01281.x.
21. Williams RJ, Spencer JP, Rice-Evans C. Flavonoids: antioxidants or signalling molecules?Free Radic Biol Med. 2004; 36: 838-49.
22. Gao J, Wang WY, Mao YW, et al. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature. 2010; 466: 1105-9.
23. Voellenkle C, van Rooij J, Cappuzzello C, et al. MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patients. Physiol Genomics. 2010; 42: 420-6.
24. Graf E. Antioxidant potential of ferulic acid. Free Radic Biol Med. 1992; 13: 435-48.
25. Wang XH, Qian RZ, Zhang W, et al. MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Clin Exp Pharmacol Physiol. 2009; 36: 181-8.
26. Meseguer S, Mudduluru G, Escamilla JM, et al. MicroRNAs-10a and -10b contribute to retinoic acid-induced differentiation of neuroblastoma cells and target the alternative splicing regulatory factor SFRS1 (SF2/ASF). J Biol Chem. 2011; 286: 4150-64.
27. Zheng L, Lv GC, Sheng J, et al. Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD. J Gastroenterol Hepatol. 2010; 25: 156-63.
28. Mukhopadhyay B, Liu J, Osei-Hyiaman D, et al. Transcriptional regulation of cannabinoid receptor-1 expression in the liver by retinoic acid acting via retinoic acid receptor-gamma. J Biol Chem. 2010; 285: 19002-11.
29. Mukhopadhyay B, Cinar R, Yin S, et al. Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liver. Proc Natl Acad Sci USA. 2011, 108: 6323-8.
30. Mukhopadhyay P, Batkai S, Rajesh M, et al. Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity. J Am Coll Cardiol. 2007; 50: 528-36.
31. Mukhopadhyay P, Horvath B, Rajesh M, et al. Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury. Free Radic Biol Med. 2011; 50: 179-95.
32. Satoh M, Minami Y, Takahashi Y, et al. Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy. J Card Fail. 2010; 16: 404-10.
33. Zampetaki A, Kiechl S, Drozdov I, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res. 2010; 107: 810-7.
34. Mishra PK, Metreveli N, Tyagi SC. MMP-9 gene ablation and TIMP-4 mitigate PAR-1-mediated cardiomyocyte dysfunction: a plausible role of dicer and miRNA. Cell Biochem Biophys. 2010; 57: 67-76.
35. Das S, Lekli I, Das M, et al. Cardioprotection with palm oil tocotrienols: comparison of different isomers. Am J Physiol Heart Circ Physiol. 2008; 294: H970-8.
36. Suzuki S, Tanaka K, Suzuki N. Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects. J Cereb Blood Flow Metab. 2009; 29: 464-79.
37. Dudley J, Das S, Mukherjee S, et al. Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose. J Nutr Biochem. 2009; 20: 443-52.
38. Das S, Das DK. Resveratrol: a therapeutic promise for cardiovascular diseases. Recent Pat Cardiovasc Drug Discov. 2007; 2: 133-8.
39. Das M, Das S, Wang P, et al. Caveolin and proteasome in tocotrienol mediated myocardial protection. Cell Physiol Biochem. 2008; 22: 287-94.
40. Das DK, Sato M, Ray PS, et al. Cardioprotection of red wine: role of polyphenolic antioxidants. Drugs Exp Clin Res. 1999; 25: 115-20.
41. Das S, Nesaretnam K, Das DK. Tocotrienols in cardioprotection. Vitam Horm. 2007; 76: 419-33.